Allosteric inhibition of Epac: computational modeling and experimental validation to identify allosteric sites and inhibitors
about
The future of EPAC-targeted therapies: agonism versus antagonismIdentification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1.Functionalized N,N-Diphenylamines as Potent and Selective EPAC2 Inhibitors.The role of Epac in the heart.The Potential of a Novel Class of EPAC-Selective Agonists to Combat Cardiovascular Inflammation.Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.
P2860
Allosteric inhibition of Epac: computational modeling and experimental validation to identify allosteric sites and inhibitors
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Allosteric inhibition of Epac: ...... llosteric sites and inhibitors
@ast
Allosteric inhibition of Epac: ...... llosteric sites and inhibitors
@en
Allosteric inhibition of Epac: ...... llosteric sites and inhibitors
@nl
type
label
Allosteric inhibition of Epac: ...... llosteric sites and inhibitors
@ast
Allosteric inhibition of Epac: ...... llosteric sites and inhibitors
@en
Allosteric inhibition of Epac: ...... llosteric sites and inhibitors
@nl
prefLabel
Allosteric inhibition of Epac: ...... llosteric sites and inhibitors
@ast
Allosteric inhibition of Epac: ...... llosteric sites and inhibitors
@en
Allosteric inhibition of Epac: ...... llosteric sites and inhibitors
@nl
P2093
P2860
P356
P1476
Allosteric inhibition of Epac: ...... llosteric sites and inhibitors
@en
P2093
Kathleen E Rogers
Loren M Brown
Nakon Aroonsakool
Paul A Insel
P2860
P304
29148-29157
P356
10.1074/JBC.M114.569319
P407
P577
2014-09-02T00:00:00Z